Published in:
01-04-2010 | Letter to the Editors
Autosomal dominant nemaline myopathy caused by a novel α-tropomyosin 3 mutation
Authors:
I. C. Kiphuth, S. Krause, H. B. Huttner, G. Dekomien, T. Struffert, R. Schröder
Published in:
Journal of Neurology
|
Issue 4/2010
Login to get access
Abstract
Nemaline myopathy (NM) is a genetically and clinically heterogenous muscle disorder, which is myopathologically characterized by nemaline bodies [
1]. Mutations in six genes have been reported to cause NM: Nebulin (
NEB Pelin 1999), α-skeletal muscle actin (
ACTA1 Nowak 1999), α-slow tropomyosin (
TPM3 Laing 1995), β-tropomyosin (
TPM2 Donner 2002), slow troponin T (
TNNT1 Johnston 2000) and cofilin 2 (
CFL2 Agrawal 2007) [
2]. The majority of cases are due to mutation in
NEB and
ACTA1 [
3,
4]. We report on the clinical, myopathological and muscle MRI findings in a German family with autosomal dominant NM due to a novel pathogenic
TPM3 mutation (p.Ala156Thr).